Potentially inappropriate screening colonoscopy in medicare patients: Variation by physician and geographic region

JAMA Internal Medicine

Volumn 173, Issue 7, 2013, Pages 542-550

  Sheffield, Kristin M ^a   Han, Yimei ^a   Kuo, Yong Fang ^a   Riall, Taylor S ^a   Goodwin, James S ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COMORBIDITY; FEMALE; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; MEDICARE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL AREA; TREATMENT INDICATION; UNITED STATES; URBAN AREA;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; COLONOSCOPY; FEMALE; HEALTH SERVICES MISUSE; HUMANS; MALE; MEDICARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TEXAS; UNITED STATES;

EID: 84876016188     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2912     Document Type: Article

References (44)

1. Holden DJ, Harris R, Porterfield DS, et al. Enhancing the Use and Quality of Colorectal Cancer Screening. Rockville, MD: Agency for Healthcare Research and Quality (US); 2010. Evidence Reports/Technology Assessments, No. 190.
2. Benarroch-Gampel J, Sheffield KM, Lin YL, Kuo YF, Goodwin JS, Riall TS. Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res. 2012;47(3, pt 1):1137-1157.
3. Singal AK, Lin YL, Kuo YF, Riall T, Goodwin JS. Primary care physicians and disparities in colorectal cancer screening in the elderly. Health Serv Res. 2013; (48): 95-113.
4. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465-473.
5. Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991-996.
6. Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005;100(11):2526-2530.
7. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171(15):1335-1343.
8. US Preventive Services Task Force. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
9. Qaseem A, Denberg TD, Hopkins RH Jr, et al; Clinical Guidelines Committee of the American College of Physicians. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378-386.
10. Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849-857, W152.
11. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U. S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
12. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U. S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-658.
13. Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004;127(6):1661-1669.
14. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med. 2003;115(2):129-133.
15. Krist AH, Jones RM, Woolf SH, et al. Timing of repeat colonoscopy: disparity between guidelines and endoscopists' recommendation. Am J Prev Med. 2007;33(6):471-478.
16. Klabunde CN, Lanier D, Breslau ES, et al. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med. 2007;22(8):1195-1205.
17. Sheridan SL, Harris RP, Woolf SH; Shared Decision-Making Workgroup of the U. S. Preventive Services Task Force. Shared decision making about screening and chemoprevention. a suggested approach from the U. S. Preventive Services Task Force. Am J Prev Med. 2004;26(1):56-66.
18. Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38(5):536-550.
19. Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005;294(4):473-481.
20. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129-2135.
21. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004;99(8):1544-1550.
22. Chao A, Connell CJ, Cokkinides V, Jacobs EJ, Calle EE, Thun MJ. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health. 2004;94(10):1775-1781.
23. Singh A, Kuo YF, Riall TS, Raju GS, Goodwin JS. Predictors of colorectal cancer following a negative colonoscopy in the Medicare population. Dig Dis Sci. 2011;56(11):3122-3128.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
25. Wennberg JE, Cooper MM. The Dartmouth Atlas of Health Care 1998. Chicago, IL: American Hospital Publishing; 1998.
26. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA. 1999;281(22):2098- 2105.
27. Sixma HJ, Spreeuwenberg PM, van der Pasch MA. Patient satisfaction with the general practitioner: a two-level analysis. Med Care. 1998;36(2):212-229.
28. Cowen ME, Strawderman RL. Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach. Med Care. 2002;40(8):650-661.
29. Beaulieu MD, Blais R, Jacques A, Battista RN, Lebeau R, Brophy J. Are patients suffering from stable angina receiving optimal medical treatment? QJM. 2001;94(6):301-308.
30. Levin B, Lieberman DA, McFarland B, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570-1595.
31. Kann BR, Margolin DA, Brill SA, et al. The importance of colonoscopy in colorectal surgeons' practices: results of a survey. Dis Colon Rectum. 2006;49(11):1763-1767.
32. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U. S. population. Cancer. 2004;100(10):2093-2103.
33. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23-29.
34. Coughlin SS, Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005;6(4):369-378.
35. Saini SD, Nayak RS, Kuhn L, Schoenfeld P. Why don't gastroenterologists follow colon polyp surveillance guidelines? results of a national survey. J Clin Gastroenterol. 2009;43(6):554-558.
36. Rossi F, Sosa JA, Aslanian HR. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists. J Clin Gastroenterol. 2008;42(10):1089-1094.
37. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology. 2010;138(6):2115-2126.
38. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [published correction appears in Am J Gastroenterol. 2009;104(6): 1613]. Am J Gastroenterol. 2009;104(3):739-750.
39. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840, 149 screening colonoscopies. Gut. 2007;56(11):1585-1589.
40. Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? a national survey of primary care physicians in the United States. Ann Intern Med. 2012;156(5):340-349.
41. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78.
42. Schultz SE, Vinden C, Rabeneck L. Colonoscopy and flexible sigmoidoscopy practice patterns in Ontario: a population-based study. Can J Gastroenterol. 2007;21(7):431-434.
43. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138(4):273-287.
44. Gawande A. The cost conundrum: what a Texas town can teach us about health care. The New Yorker. June 1, 2009. http://www.newyorker.com/reporting/ 2009/06/01/090601fa-fact-gawande.